What is the most important test to do before starting Oral Contraceptive Pills (OCP) in a patient with Abnormal Uterine Bleeding (AUB) for 6 months?

Most Important Test Before Starting OCPs in AUB

Pelvic ultrasound (combined transabdominal and transvaginal with Doppler) is the most important test before initiating oral contraceptive pills in a patient with 6 months of abnormal uterine bleeding. 1

Rationale for Pelvic Ultrasound as First-Line

Starting OCPs without imaging risks missing serious pathology that would be temporarily suppressed by hormonal contraception, delaying diagnosis of conditions like endometrial cancer or significant structural lesions. 1 The ultrasound provides comprehensive evaluation of the uterus and adnexa, identifying structural causes including:

• Endometrial polyps 1
• Adenomyosis 1
• Leiomyomas (fibroids) 1
• Endometrial hyperplasia or malignancy 1

The ACR recommends combined transabdominal and transvaginal ultrasound with Doppler as the most appropriate initial imaging study for abnormal uterine bleeding. 2, 3 Transabdominal imaging is essential when the uterus is enlarged, as the limited field of view of transvaginal ultrasound alone cannot capture all portions of an enlarged uterus or tumor. 2

Why Not the Other Options

FSH and LH (Options A & B)

The CDC classifies hormonal testing such as FSH and LH as "Class C" tests that do not contribute substantially to safe oral contraceptive initiation. 1 These tests are unnecessary before starting OCPs and do not help identify the structural or malignant causes that must be excluded before masking symptoms with hormonal therapy. 1

Endometrial Biopsy (Option D)

Endometrial biopsy is not the first test—it is indicated based on age and ultrasound findings. 1 The need for endometrial biopsy is guided by ultrasound results, particularly for:

• Women ≥35 years old 1, 3
• Younger women with risk factors for endometrial cancer 1
• Ultrasound showing focal endometrial abnormality or thickened endometrium 1

The FDA labeling for oral contraceptives explicitly states that "in undiagnosed persistent or recurrent abnormal bleeding from the vagina, adequate diagnostic measures are indicated to rule out pregnancy or malignancy" before initiating treatment. 4 This diagnostic workup begins with imaging, not tissue sampling. 1

Clinical Algorithm

1. Obtain pelvic ultrasound first (transvaginal and transabdominal with Doppler) to assess endometrial thickness and architecture, identify structural lesions, and evaluate for masses 1

2. Consider endometrial biopsy if:

   • Patient is ≥35 years old 1
   • Risk factors for endometrial cancer present 1
   • Ultrasound shows focal endometrial abnormality or thickened endometrium 1

3. Additional baseline testing should include pregnancy test, TSH, prolactin levels, and CBC with platelets 3

Common Pitfalls to Avoid

Do not prescribe OCPs to suppress bleeding without first obtaining imaging. 1 The FDA warns that breakthrough bleeding and abnormal vaginal bleeding require exclusion of non-functional causes, and "adequate diagnostic measures are indicated to rule out pregnancy or malignancy" before continuing hormonal contraception. 4

Endometrial biopsy alone should not be used to rule out focal lesions, as it has variable sensitivity for detecting polyps and submucosal fibroids. 3 Ultrasound with or without saline infusion sonohysterography has high sensitivity and can distinguish between leiomyomas and endometrial polyps with 97% accuracy. 2, 5